Latest news Fulcrum Therapeutics announces phase 3 clinical trial of its drug losmapimod in people with FSHD Read more New research reveals 110,000 people in the UK now live with muscle-wasting conditions MDUK publishes landmark report on impact of Covid-19 See all news Ways you can get involved Donate For over 50 years, we've been here for people living with muscle-wasting conditions. We couldn't do this without your help. Thank you. Find out more Fundraise Support for our work is more crucial than ever, so we've got lots of ideas about how you can help us fundraise. Find out more Volunteer Our brilliant volunteers help us deliver services, fundraise and raise awareness about muscle-wasting conditions. Find out more
Fulcrum Therapeutics announces phase 3 clinical trial of its drug losmapimod in people with FSHD Read more
Donate For over 50 years, we've been here for people living with muscle-wasting conditions. We couldn't do this without your help. Thank you. Find out more
Fundraise Support for our work is more crucial than ever, so we've got lots of ideas about how you can help us fundraise. Find out more
Volunteer Our brilliant volunteers help us deliver services, fundraise and raise awareness about muscle-wasting conditions. Find out more